Ionis Pharmaceuticals (IONS) P/E ratio

P/E ratio · fiscal 2019
31.8×

The P/E ratio of Ionis Pharmaceuticals (IONS) was 31.8× at the end of fiscal 2019 (December 31, 2019). That is 21.7% higher than the 26.1× of fiscal 2018. Figures as of 18 Nov 2026, 06:19 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio, fiscal 2019
31.8×
Change on fiscal 2018
+21.7%
Highest on record
335.3×fiscal 2017
Lowest on record
7.0×fiscal 2009
Fiscal years on record
42009–2019

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Ionis Pharmaceuticals P/E ratio, in more detail

Across the 4 fiscal year-ends on record (2009–2019), the highest was 335.3× in fiscal 2017 and the lowest 7.0× in fiscal 2009.

History · 4 fiscal years

P/E ratio at each fiscal year-end

Ionis Pharmaceuticals P/E ratio, year by year

Ionis Pharmaceuticals (IONS) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
2025——$79.11-$2.38
2024——$34.96-$3.04
2023——$50.59-$2.56
2022——$37.77-$1.90
2021——$30.43-$0.20
2020——$56.54-$3.18
201931.8× 21.7% up$60.41$1.90
201826.1× 92.2% down$54.06$2.07
2017335.3×—$50.30$0.15
2016——$47.83-$0.50
2015——$61.93-$0.74
2014——$61.74—
2013——$39.84—
2012——$10.44—
2011——$7.21-$0.85
2010——$10.12-$0.62
20097.0×—$11.11$1.58
2008——$14.18-$0.19

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

P/E ratio at health care companies of similar size

P/E ratio of Ionis Pharmaceuticals and comparable companies
CompanyP/E ratio
Edgewise Therapeutics EWTX5.2×
LivaNova LIVN26.5×

Price over the last twelve months' earnings per share, as the market data feed reports it.

More on IONS

Ionis Pharmaceuticals, figure by figure

Ionis Pharmaceuticals (IONS) overview: price, valuation and scorecardAll health care companies by market value

Ionis Pharmaceuticals P/E ratio: questions and answers

What is Ionis Pharmaceuticals's P/E ratio?

The P/E ratio of Ionis Pharmaceuticals (IONS) was 31.8× at the end of fiscal 2019 (December 31, 2019). That is 21.7% higher than the 26.1× of fiscal 2018.

What are the highest and lowest P/E ratio figures on record for Ionis Pharmaceuticals?

Across the 4 fiscal year-ends on record (2009–2019), the highest was 335.3× in fiscal 2017 and the lowest 7.0× in fiscal 2009.

How is Ionis Pharmaceuticals's P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ionis Pharmaceuticals (IONS) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/IONS/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.